NASDAQ
C4 Therapeutics, Inc. (CCCC) has a current ratio of 7.81x as of Monday, May 25, 2026. This represents a 25.74% increase compared to its 12-month average of 6.21x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.